$15.38
+0.01 (+0.07%)
As of Jun 22, 9:41 PM ET ·
Analyst Consensus
Buy
18
Analysts
High
Coverage
Buy 12 67%
Hold 5 28%
Sell 1 6%
Price Target
Analyst Price Target +698.6% upside
Low Target $69.38
Average Target $122.82
High Target $167.78
Current Price $15.38
Current
$15.38
Target
$122.82
$69.38 $122.82 avg $167.78
Scenario Analysis
Bear Case
$69.38
351.1%
Low target
Base Case
$122.82
+698.6%
Avg target
Bull Case
$167.78
+990.9%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$17.53
-12.3% from high
52-Week Low
$8.63
+78.2% from low
50-Day SMA
$13.14
+17.0% vs SMA
200-Day SMA
$10.55
+45.8% vs SMA
RSI (14)
87.6
Overbought
Target vs 52W High
$122.82
+600.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.7%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +29.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +37.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +35.2%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +219.0%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +176.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -32.3%